Richard A. King
No Rating Available
(Learn About Our Rating System)

Richard A. King, MD

Languages spoken: English

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000

  • Dr. Richard King is an assistant professor in the division of hematology and hematologic malignancies at the University of Utah. He earned his medical degree at the Ohio State University, then completed his internal medicine residency and his hematology and oncology fellowship at the University of Michigan. He specializes in nonmalignant hematologic disorders. His clinical interests include congenital and acquired anemia, bone marrow failure syndromes, porphyria, iron disorders, and platelet disorders. His research has focused on congenital dyserythropoietic anemias with the goal of better understanding the mechanisms of these disorders to lead to new treatments.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

  • Dr. Richard King is an assistant professor in the division of hematology and hematologic malignancies at the University of Utah. He earned his medical degree at the Ohio State University, then completed his internal medicine residency and his hematology and oncology fellowship at the University of Michigan. He specializes in nonmalignant hematologic disorders. His clinical interests include congenital and acquired anemia, bone marrow failure syndromes, porphyria, iron disorders, and platelet disorders. His research has focused on congenital dyserythropoietic anemias with the goal of better understanding the mechanisms of these disorders to lead to new treatments.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    National Board of Medical Examiners

    Education history

    Fellowship Hematology/Oncology - University of Michigan Health System Fellow
    Residency Internal Medicine - University of Michigan Health System Resident
    Professional Medical Medicine - Ohio State University College of Medicine M.D.
    Undergraduate Major: Biomedical Engineering; Minor: Mathematics - University of Cincinnati B.S.

    Selected Publications

    Journal Article

    1. King R, Schaefer J, Sahai V, Griffith KA, Sood SL (2022). Retrospective Cohort Analysis of Aspirin Use and Venous Thromboembolism in Patients with Pancreatic Cancer and an Indwelling Central Venous Catheter. TH Open, 6(3), e221-e229. (Read full article)
    2. King R, Lin Z, Balbin-Cuesta G, Myers G, Friedman A, Zhu G, McGee B, Saunders TL, Kurita R, Nakamura Y, Engel JD, Reddy P, Khoriaty R (2021). SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II. Sci Adv, 7(48), eabj5293. (Read full article)
    3. Kim S, Khoriaty R, Li L, McClune M, Kalfa TA, Wu J, Peltier D, Fujiwara H, Sun Y, Oravecz-Wilson K, King RA, Ginsburg D, Reddy P (2020). ER-to-Golgi transport and SEC23-dependent COPII vesicles regulate T cell alloimmunity. J Clin Invest, 131(2). (Read full article)
    4. Lin Z, King R, Tang V, Myers G, Balbin-Cuesta G, Friedman A, McGee B, Desch K, Ozel AB, Siemieniak D, Reddy P, Emmer B, Khoriaty R (2020). The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion. Mol Cell Biol, 40(23). (Read full article)
    5. Reid JH, Durant KM, Chen SL, Perissinotti AJ, King R, Khoriaty R, Marini BL (2020). Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura. J Oncol Pharm Pract, 26(7), 1695-1702. (Read full article)
    6. Oren L, Khosla S, Murugappan S, King R, Gutmark E (2009). Role of subglottal shape in turbulence reduction. Ann Otol Rhinol Laryngol, 118(3), 232-40. (Read full article)

    Review

    1. King R, Gallagher PJ, Khoriaty R (2021). The congenital dyserythropoieitic anemias: genetics and pathophysiology. [Review]. Curr Opin Hematol, 29(3), 126-136. (Read full article)